Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.

de Goeij L, Westhoff E, Witjes JA, Aben KK, Kampman E, Kiemeney LA, Vrieling A.

BMJ Open. 2019 Oct 16;9(10):e030396. doi: 10.1136/bmjopen-2019-030396.

2.

Mapping Geospatial Processes Affecting the Environmental Fate of Agricultural Pesticides in Africa.

Hendriks CMJ, Gibson HS, Trett A, Python A, Weiss DJ, Vrieling A, Coleman M, Gething PW, Hancock PA, Moyes CL.

Int J Environ Res Public Health. 2019 Sep 20;16(19). pii: E3523. doi: 10.3390/ijerph16193523.

3.

Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients.

Westhoff E, Kampman E, Aben KK, Hendriks IG, Witjes JA, Kiemeney LA, Vrieling A.

Urol Oncol. 2019 Sep;37(9):573.e1-573.e8. doi: 10.1016/j.urolonc.2019.04.016. Epub 2019 May 8.

4.

One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.

Vrieling A, Bueno-De-Mesquita HB, Ros MM, Kampman E, Aben KK, Büchner FL, Jansen EH, Roswall N, Tjønneland A, Boutron-Ruault MC, Cadeau C, Chang-Claude J, Kaaks R, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Sieri S, Palli D, Panico S, Peeters PH, Weiderpass E, Skeie G, Jakszyn P, Chirlaque MD, Ardanaz E, Sánchez MJ, Ehrnström R, Malm J, Ljungberg B, Khaw KT, Wareham NJ, Brennan P, Johansson M, Riboli E, Kiemeney LA.

Int J Cancer. 2019 Nov 1;145(9):2349-2359. doi: 10.1002/ijc.32165. Epub 2019 Feb 13.

5.

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer.

Vrieling A.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S702-S705. doi: 10.21037/tau.2018.10.17. No abstract available.

6.

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.

Fernández MI, Brausi M, Clark PE, Cookson MS, Grossman HB, Khochikar M, Kiemeney LA, Malavaud B, Sanchez-Salas R, Soloway MS, Svatek RS, Vikram R, Vrieling A, Kamat AM.

World J Urol. 2019 Jan;37(1):3-13. doi: 10.1007/s00345-018-2436-y. Epub 2018 Aug 13. Review.

PMID:
30105454
7.

Smoking intensity and bladder cancer aggressiveness at diagnosis.

Barbosa ALA, Vermeulen SHHM, Aben KK, Grotenhuis AJ, Vrieling A, Kiemeney LA.

PLoS One. 2018 Mar 23;13(3):e0194039. doi: 10.1371/journal.pone.0194039. eCollection 2018.

8.

Most response-inducing strategies do not increase participation in observational studies: a systematic review and meta-analysis.

van Gelder MMHJ, Vlenterie R, IntHout J, Engelen LJLPG, Vrieling A, van de Belt TH.

J Clin Epidemiol. 2018 Jul;99:1-13. doi: 10.1016/j.jclinepi.2018.02.019. Epub 2018 Mar 5.

PMID:
29518475
9.

Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.

Westhoff E, Witjes JA, Fleshner NE, Lerner SP, Shariat SF, Steineck G, Kampman E, Kiemeney LA, Vrieling A.

Bladder Cancer. 2018 Jan 20;4(1):91-112. doi: 10.3233/BLC-170147.

10.

Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.

Westhoff E, Wu X, Kiemeney LA, Lerner SP, Ye Y, Huang M, Dinney CP, Vrieling A, Tu H.

Int J Cancer. 2018 May 1;142(9):1797-1804. doi: 10.1002/ijc.31214. Epub 2017 Dec 26.

11.

Lifestyle and bladder cancer prevention: no consistent evidence from cohort studies.

Vrieling A.

Eur J Epidemiol. 2017 Nov;32(11):1033-1035. doi: 10.1007/s10654-017-0306-3. Epub 2017 Sep 4. No abstract available.

PMID:
28871470
12.

Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.

Vrieling A, Kampman E, Knijnenburg NC, Mulders PF, Sedelaar JPM, Baracos VE, Kiemeney LA.

Eur Urol Focus. 2018 Apr;4(3):420-434. doi: 10.1016/j.euf.2016.11.009. Epub 2016 Dec 4.

13.

Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial.

Vrieling A, Visser A, Hoedjes M, Hurks M, Gómez García E, Hoogerbrugge N, Kampman E.

Clin Genet. 2018 Jan;93(1):67-77. doi: 10.1111/cge.13076. Epub 2017 Sep 29.

PMID:
28632915
14.

Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration.

Visser A, Vrieling A, Murugesu L, Hoogerbrugge N, Kampman E, Hoedjes M.

PLoS One. 2017 Jun 1;12(6):e0178205. doi: 10.1371/journal.pone.0178205. eCollection 2017.

15.

Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.

Westerink NL, Nuver J, Lefrandt JD, Vrieling AH, Gietema JA, Walenkamp AM.

Crit Rev Oncol Hematol. 2016 Dec;108:128-136. doi: 10.1016/j.critrevonc.2016.10.011. Epub 2016 Nov 3. Review.

16.

Predicting mobility outcome in lower limb amputees with motor ability tests used in early rehabilitation.

Spaan MH, Vrieling AH, van de Berg P, Dijkstra PU, van Keeken HG.

Prosthet Orthot Int. 2017 Apr;41(2):171-177. doi: 10.1177/0309364616670397. Epub 2016 Oct 22.

PMID:
27770064
17.

Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview.

Westhoff E, Maria de Oliveira-Neumayer J, Aben KK, Vrieling A, Kiemeney LA.

Eur J Cancer. 2016 Jun;60:136-45. doi: 10.1016/j.ejca.2016.03.071. Epub 2016 Apr 25. Review.

18.

Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.

Munyua PM, Murithi RM, Ithondeka P, Hightower A, Thumbi SM, Anyangu SA, Kiplimo J, Bett B, Vrieling A, Breiman RF, Njenga MK.

PLoS One. 2016 Jan 25;11(1):e0144570. doi: 10.1371/journal.pone.0144570. eCollection 2016.

19.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.

Obi N, Heinz J, Seibold P, Vrieling A, Rudolph A, Chang-Claude J, Berger J, Flesch-Janys D.

Int J Cancer. 2016 May 1;138(9):2098-108. doi: 10.1002/ijc.29951. Epub 2015 Dec 30.

20.

The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.

Grotenhuis AJ, Ebben CW, Aben KK, Witjes JA, Vrieling A, Vermeulen SH, Kiemeney LA.

Urol Oncol. 2015 Feb;33(2):65.e9-17. doi: 10.1016/j.urolonc.2014.06.002. Epub 2014 Jul 9.

21.

Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake.

Seibold P, Vrieling A, Heinz J, Obi N, Sinn HP, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol. 2014 Aug;38(4):419-26. doi: 10.1016/j.canep.2014.05.006. Epub 2014 Jun 17.

PMID:
24950597
22.

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.

Rafnar T, Sulem P, Thorleifsson G, Vermeulen SH, Helgason H, Saemundsdottir J, Gudjonsson SA, Sigurdsson A, Stacey SN, Gudmundsson J, Johannsdottir H, Alexiusdottir K, Petursdottir V, Nikulasson S, Geirsson G, Jonsson T, Aben KK, Grotenhuis AJ, Verhaegh GW, Dudek AM, Witjes JA, van der Heijden AG, Vrieling A, Galesloot TE, De Juan A, Panadero A, Rivera F, Hurst C, Bishop DT, Sak SC, Choudhury A, Teo MT, Arici C, Carta A, Toninelli E, de Verdier P, Rudnai P, Gurzau E, Koppova K, van der Keur KA, Lurkin I, Goossens M, Kellen E, Guarrera S, Russo A, Critelli R, Sacerdote C, Vineis P, Krucker C, Zeegers MP, Gerullis H, Ovsiannikov D, Volkert F, Hengstler JG, Selinski S, Magnusson OT, Masson G, Kong A, Gudbjartsson D, Lindblom A, Zwarthoff E, Porru S, Golka K, Buntinx F, Matullo G, Kumar R, Mayordomo JI, Steineck DG, Kiltie AE, Jonsson E, Radvanyi F, Knowles MA, Thorsteinsdottir U, Kiemeney LA, Stefansson K.

Hum Mol Genet. 2014 Oct 15;23(20):5545-57. doi: 10.1093/hmg/ddu264. Epub 2014 May 26.

23.

Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study.

Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K.

Psychooncology. 2015 Jan;24(1):40-6. doi: 10.1002/pon.3581. Epub 2014 May 17.

PMID:
24839264
24.

Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition.

Leenders M, Leufkens AM, Siersema PD, van Duijnhoven FJ, Vrieling A, Hulshof PJ, van Gils CH, Overvad K, Roswall N, Kyrø C, Boutron-Ruault MC, Fagerhazzi G, Cadeau C, Kühn T, Johnson T, Boeing H, Aleksandrova K, Trichopoulou A, Klinaki E, Androulidaki A, Palli D, Grioni S, Sacerdote C, Tumino R, Panico S, Bakker MF, Skeie G, Weiderpass E, Jakszyn P, Barricarte A, María Huerta J, Molina-Montes E, Argüelles M, Johansson I, Ljuslinder I, Key TJ, Bradbury KE, Khaw KT, Wareham NJ, Ferrari P, Duarte-Salles T, Jenab M, Gunter MJ, Vergnaud AC, Wark PA, Bueno-de-Mesquita HB.

Int J Cancer. 2014 Dec 15;135(12):2930-9. doi: 10.1002/ijc.28938. Epub 2014 May 14.

25.

Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.

Ali AM, Schmidt MK, Bolla MK, Wang Q, Gago-Dominguez M, Castelao JE, Carracedo A, Garzón VM, Bojesen SE, Nordestgaard BG, Flyger H, Chang-Claude J, Vrieling A, Rudolph A, Seibold P, Nevanlinna H, Muranen TA, Aaltonen K, Blomqvist C, Matsuo K, Ito H, Iwata H, Horio A, John EM, Sherman M, Lissowska J, Figueroa J, Garcia-Closas M, Anton-Culver H, Shah M, Hopper JL, Trichopoulou A, Bueno-de-Mesquita B, Krogh V, Weiderpass E, Andersson A, Clavel-Chapelon F, Dossus L, Fagherazzi G, Peeters PH, Olsen A, Wishart GC, Easton DF, Borgquist S, Overvad K, Barricarte A, González CA, Sánchez MJ, Amiano P, Riboli E, Key T, Pharoah PD.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):934-45. doi: 10.1158/1055-9965.EPI-13-0901. Epub 2014 Mar 17.

26.

Determinants of newly diagnosed comorbidities among breast cancer survivors.

Obi N, Gornyk D, Heinz J, Vrieling A, Seibold P, Chang-Claude J, Flesch-Janys D.

J Cancer Surviv. 2014 Sep;8(3):384-93. doi: 10.1007/s11764-013-0338-y. Epub 2014 Feb 26.

PMID:
24570215
27.

Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.

Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, Linseisen J, Obi N, Heinz J, Flesch-Janys D, Chang-Claude J.

Int J Cancer. 2014 Aug 15;135(4):923-33. doi: 10.1002/ijc.28729. Epub 2014 Feb 5.

28.

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, Flesch-Janys D, Chang-Claude J.

Int J Cancer. 2014 Jun 15;134(12):2972-83. doi: 10.1002/ijc.28628. Epub 2013 Dec 7.

29.

Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Nickels S, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J.

PLoS One. 2013 Sep 25;8(9):e75088. doi: 10.1371/journal.pone.0075088. eCollection 2013.

30.

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.

Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Silva Idos S, Peto J, Humphreys MK, Wang J, Cordina-Duverger E, Menegaux F, Nordestgaard BG, Bojesen SE, Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Brauch H, Brüning T, Harth V; Genica Network, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM; kConFab; AOCS Management Group, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody MM, Guénel P, Pharoah PD, Schmidt MK, Hall P, Easton DF, Garcia-Closas M, Milne RL, Chang-Claude J.

PLoS Genet. 2013;9(3):e1003284. doi: 10.1371/journal.pgen.1003284. Epub 2013 Mar 27.

31.

Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer.

Schmidt ME, Chang-Claude J, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Steindorf K.

Int J Cancer. 2013 Sep 15;133(6):1431-40. doi: 10.1002/ijc.28130. Epub 2013 Mar 18.

32.

Constructing boundary-consistent population time series for the municipalities of the Netherlands, 1988-2011.

Vrieling A, Melser C.

Popul Stud (Camb). 2013 Jul;67(2):195-208. doi: 10.1080/00324728.2012.754049. Epub 2013 Jan 22.

PMID:
23336364
33.

Dietary patterns and survival in German postmenopausal breast cancer survivors.

Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J.

Br J Cancer. 2013 Jan 15;108(1):188-92. doi: 10.1038/bjc.2012.521. Epub 2012 Nov 20.

34.

Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.

Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F, Vogel U, Tjønneland A, Overvad K, Tolstrup JS, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Boeing H, Bergmann M, Trichopoulou A, Katsoulis M, Trichopoulos D, Krogh V, Panico S, Sacerdote C, Palli D, Tumino R, Peeters PH, van Gils CH, Bueno-de-Mesquita B, Vrieling A, Lund E, Hjartåker A, Agudo A, Suarez LR, Arriola L, Chirlaque MD, Ardanaz E, Sánchez MJ, Manjer J, Lindkvist B, Hallmans G, Palmqvist R, Allen N, Key T, Khaw KT, Slimani N, Rinaldi S, Romieu I, Boffetta P, Romaguera D, Norat T, Riboli E.

Eur J Clin Nutr. 2012 Dec;66(12):1303-8. doi: 10.1038/ejcn.2012.173. Epub 2012 Nov 14.

PMID:
23149980
35.

Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study.

Vrieling A, Buck K, Heinz J, Obi N, Benner A, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res Treat. 2012 Nov;136(1):195-207. doi: 10.1007/s10549-012-2230-2. Epub 2012 Sep 11.

PMID:
22961011
36.

Controlling horizontal deceleration during gait termination in transfemoral amputees: measurements and simulations.

van Keeken HG, Vrieling AH, Hof AL, Postema K, Otten B.

Med Eng Phys. 2013 May;35(5):583-90. doi: 10.1016/j.medengphy.2012.07.002. Epub 2012 Aug 15.

PMID:
22901854
37.

Walking, bicycling, and sports in postmenopausal breast cancer survivors--results from a German patient cohort study.

Bock C, Schmidt ME, Vrieling A, Chang-Claude J, Steindorf K.

Psychooncology. 2013 Jun;22(6):1291-8. doi: 10.1002/pon.3134. Epub 2012 Jul 16.

PMID:
22807316
38.

The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study.

Zaineddin AK, Buck K, Vrieling A, Heinz J, Flesch-Janys D, Linseisen J, Chang-Claude J.

Nutr Cancer. 2012;64(5):652-65. doi: 10.1080/01635581.2012.683227. Epub 2012 May 16.

PMID:
22591208
39.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, Nickels S, Brauch H; GENICA Network, Ko YD, Fischer HP, Schmutzler RK, Meindl A, Bartram CR, Schott S, Engel C, Godwin AK, Weaver J, Pathak HB, Sharma P, Brenner H, Müller H, Arndt V, Stegmaier C, Miron P, Yannoukakos D, Stavropoulou A, Fountzilas G, Gogas HJ, Swann R, Dwek M, Perkins A, Milne RL, Benítez J, Zamora MP, Pérez JI, Bojesen SE, Nielsen SF, Nordestgaard BG, Flyger H, Guénel P, Truong T, Menegaux F, Cordina-Duverger E, Burwinkel B, Marmé F, Schneeweiss A, Sohn C, Sawyer E, Tomlinson I, Kerin MJ, Peto J, Johnson N, Fletcher O, Dos Santos Silva I, Fasching PA, Beckmann MW, Hartmann A, Ekici AB, Lophatananon A, Muir K, Puttawibul P, Wiangnon S, Schmidt MK, Broeks A, Braaf LM, Rosenberg EH, Hopper JL, Apicella C, Park DJ, Southey MC, Swerdlow AJ, Ashworth A, Orr N, Schoemaker MJ, Anton-Culver H, Ziogas A, Bernstein L, Dur CC, Shen CY, Yu JC, Hsu HM, Hsiung CN, Hamann U, Dünnebier T, Rüdiger T, Ulmer HU, Pharoah PP, Dunning AM, Humphreys MK, Wang Q, Cox A, Cross SS, Reed MW, Hall P, Czene K, Ambrosone CB, Ademuyiwa F, Hwang H, Eccles DM, Garcia-Closas M, Figueroa JD, Sherman ME, Lissowska J, Devilee P, Seynaeve C, Tollenaar RA, Hooning MJ, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, John EM, Miron A, Alnæs GG, Kristensen V, Børresen-Dale AL, Giles GG, Baglietto L, McLean CA, Severi G, Kosel ML, Pankratz VS, Slager S, Olson JE, Radice P, Peterlongo P, Manoukian S, Barile M, Lambrechts D, Hatse S, Dieudonne AS, Christiaens MR, Chenevix-Trench G; kConFab Investigators; AOCS Group, Beesley J, Chen X, Mannermaa A, Kosma VM, Hartikainen JM, Soini Y, Easton DF, Couch FJ.

Cancer Res. 2012 Apr 1;72(7):1795-803. doi: 10.1158/0008-5472.CAN-11-3364. Epub 2012 Feb 13.

40.

Postmenopausal sex hormones in relation to body fat distribution.

Liedtke S, Schmidt ME, Vrieling A, Lukanova A, Becker S, Kaaks R, Zaineddin AK, Buck K, Benner A, Chang-Claude J, Steindorf K.

Obesity (Silver Spring). 2012 May;20(5):1088-95. doi: 10.1038/oby.2011.383. Epub 2012 Jan 12.

41.

Impact of Diet, Body Mass Index, and Physical Activity on Cancer Survival.

Kampman E, Vrieling A, van Duijnhoven FJ, Winkels RM.

Curr Nutr Rep. 2012 Jan 7;1:30-36. eCollection 2012. Review.

42.

Principles of obstacle avoidance with a transfemoral prosthetic limb.

van Keeken HG, Vrieling AH, Hof AL, Postema K, Otten B.

Med Eng Phys. 2012 Oct;34(8):1109-16. doi: 10.1016/j.medengphy.2011.11.017. Epub 2011 Dec 22.

PMID:
22197358
43.

Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.

Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K.

J Cancer Surviv. 2012 Mar;6(1):11-9. doi: 10.1007/s11764-011-0197-3. Epub 2011 Dec 11.

PMID:
22160661
44.

Stabilizing moments of force on a prosthetic knee during stance in the first steps after gait initiation.

van Keeken HG, Vrieling AH, Hof AL, Postema K, Otten B.

Med Eng Phys. 2012 Jul;34(6):733-9. doi: 10.1016/j.medengphy.2011.09.017. Epub 2011 Oct 12.

PMID:
21996358
45.

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.

Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Chang-Claude J, Nickels S, Vrieling A, Flesch-Janys D, Wang-Gohrke S, Eilber U, Bogdanova N, Antonenkova N, Runnebaum IB, Dörk T, Goodman MT, Lurie G, Wilkens LR, Matsuno RK, Kiemeney LA, Aben KK, Marees T, Massuger LF, Fridley BL, Vierkant RA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Cook LS, Le ND, Brooks-Wilson A, Kelemen LE, Campbell I, Gayther SA, Ramus SJ, Gentry-Maharaj A, Menon U, Ahmed S, Baynes C, Pharoah PD; kConFab Investigators; Australian Ovarian Cancer Study Group; ABCTB Investigators, Muir K, Lophatananon A, Chaiwerawattana A, Wiangnon S, Macgregor S, Easton DF, Reddel RR, Goode EL, Chenevix-Trench G; Ovarian Cancer Association Consortium.

PLoS One. 2011;6(9):e24987. doi: 10.1371/journal.pone.0024987. Epub 2011 Sep 15.

46.

7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium.

Milne RL, Lorenzo-Bermejo J, Burwinkel B, Malats N, Arias JI, Zamora MP, Benítez J, Humphreys MK, García-Closas M, Chanock SJ, Lissowska J, Sherman ME, Mannermaa A, Kataja V, Kosma VM, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Anton-Culver H, Ziogas A, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Liu J, Irwanto AK, Kang D, Yoo KY, Noh DY, Couch FJ, Olson JE, Wang X, Fredericksen Z, Nordestgaard BG, Bojesen SE, Flyger H, Margolin S, Lindblom A, Fasching PA, Schulz-Wendtland R, Ekici AB, Beckmann MW, Wang-Gohrke S, Shen CY, Yu JC, Hsu HM, Wu PE, Giles GG, Severi G, Baglietto L, English DR, Cox A, Brock I, Elliott G, Reed MW, Beesley J, Chen X, Investigators K; AOCS Group, Fletcher O, Gibson L, dos Santos Silva I, Peto J, Frank B, Heil J, Meindl A, Chang-Claude J, Hein R, Vrieling A, Flesch-Janys D, Southey MC, Smith L, Apicella C, Hopper JL, Dunning AM, Pooley KA, Pharoah PD, Hamann U, Pesch B, Ko YD; GENICA Network, Easton DF, Chenevix-Trench G.

J Med Genet. 2011 Oct;48(10):698-702. doi: 10.1136/jmedgenet-2011-100303.

47.

Physical activity in a German breast cancer patient cohort: one-year trends and characteristics associated with change in activity level.

Huy C, Schmidt ME, Vrieling A, Chang-Claude J, Steindorf K.

Eur J Cancer. 2012 Feb;48(3):297-304. doi: 10.1016/j.ejca.2011.08.005. Epub 2011 Sep 14.

PMID:
21920730
48.

Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.

Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, Flesch-Janys D, Chang-Claude J.

Br J Cancer. 2011 Oct 11;105(8):1151-7. doi: 10.1038/bjc.2011.374. Epub 2011 Sep 13.

49.

Serum enterolactone and prognosis of postmenopausal breast cancer.

Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, Linseisen J, Flesch-Janys D, Chang-Claude J.

J Clin Oncol. 2011 Oct 1;29(28):3730-8. doi: 10.1200/JCO.2011.34.6478. Epub 2011 Sep 6.

PMID:
21900115
50.

Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.

James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodríguez L, Buckland G, Sánchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham N, Key TJ, Allen NE, Romieu I, Siddiq A, Cox D, Riboli E, Kaaks R.

Cancer Prev Res (Phila). 2011 Oct;4(10):1626-35. doi: 10.1158/1940-6207.CAPR-11-0090. Epub 2011 Aug 2.

Supplemental Content

Loading ...
Support Center